Clinical Trial Update: Clinical Study Evaluating the Safety of Lactobacillus Probiotic in Children With Drug Resistant Epilepsy [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 safety study evaluating a Lactobacillus probiotic in children with drug-resistant epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Lactobacillus probiotic (Lactobacillus)

Snippet

Sponsor: Tanta University | Conditions: Drug Resistant Epilepsy | Phase 2 | Status: COMPLETED